다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Immune network : official journal of the Korean association of immunobiologists, v.4 no.2, 2004년, pp.94 - 99
심지영 (원자력의학원 면역학연구실, 고려대학교 생명공학과) , 정인성 (원자력의학원 면역학연구실) , 김찬화 (고려대학교 생명공학과) , 윤연숙 (원자력의학원 면역학연구실) , 송지영 (원자력의학원 면역학연구실)
AI-Helper
Background: We previously reported that ginsan, a polysaccharide extracted from Panax ginseng had an immunostimulatory activity such as mitogenic activity, activation of macrophages and killer cells, and production of a variety of cytokines which resulted in antitumor and antiseptic effects. We furt...
Wimer BM: The ideal biological response modifier. Mol Biotherapy 1;311-317, 1989
Talmadge JE, Herbermann RB: The preclinical screening laboratory: Evaluation of immunomodulatory and therapeutic properties of biological response modifiers. Cancer Treat Reports 70;171-182, 1986
Terry WD, Rosenberg SA: Immunotherapy of Human Cancer. Elsevier North-Holland. New York, 1982
Herbermann RB: Biological response modifiers for the treatment of cancer. In: Tsubura E, Urashizaki I, Aoki T, Sone S, Kaneto Y eds: Rationale of Biological response Modifiers in Cancer Treatment, p240-255, Excepta Medica, Princeton, 1985
Talmadge JE, Herberman RB: The preclinical screening laboratory: Evaluation of immunomodulatory and therapeutic properties of biological response modifiers. Cancer Treat Rep 70;171-182, 1986
Song JY, Han SK, Son EH, Pyo SN, Yun YS, Yi SY: Induction of secretory and tumoricidal activities in peritoneal macrophages by ginsan. Int Immunopharmacol 2;857-865, 2002
Lee YS, Jung IS, Lee IR, Kim KW, Hong WS, Yun YS:Activation of multiple effector pathways of immune system by the antineoplastic immunomodulator acidic polysaccharide Ginsan isolated from Panax ginseng. Anticancer Res 17;323-332, 1997
Riggi SJ, DiLuzio NR: Identification of a reticuloendothelial stimulating agent in zymosan. Am J Physiol 200;297-300, 1961
Bacon JSD, Farmer VC, Jones D, Taylor IF: The glucan component of the cell wall of Baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultra- structure. Biochem J 114;556-557, 1969
Phaff HJ: Cell wall of yeasts. Annu Rev Microbiol 17;15-30, 1963
Zakany M, Chihara G, Fachet J: Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts. Int J Cancer 25;371-376, 1980
Singh PP, Whistler RL, Tokuzen R, Nakahara W: Scleroglucan, an antitumor polysaccharide from Sclerotium glucanicum. Carbohy Res 37;245-247, 1974
DiLuzio NR, Williams DL, McNamee RB, Edwards BF, Kitahama A: Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer 24;773-779, 1979
Reynolds JA, Kastello MD, Harrington DG, Crabbs CL, Peters CJ, Jemski JV, Scott GH, DiLuzio NR: Glucan-induced enhancem ent of host resistance to selected infectious diseases. Infect Immun 30;51-57, 1980
Tateishi T, Ohno N, Adahi Y, Yadomae T: Increases in Hematopoietic Responses Caused By $\beta$ -Glucans in Mice. Biosci Biotech Biochem 61;1548-1553, 1997
Browder W, Williams DL, Lucore P, Pretus H, Jones E, McNamee RB: Effect of enhanced macrophage function on early wound healing. Surgery 104;224-230, 1988
Ohno N, Asada N, Adachi Y, Yodomae Y: Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1\longrightarrow3)-beta-D-glucans in mice. Biol Pharm Bull 18;126-133, 1995
Ohno N, Miura N, Chiba N, Adachi Y, Yadomae T: Comparison of the immunopharmacological activities of triple and singlehelical schizophyllan in mice. Biol Pharm Bull 18;1242-1247, 1995
Kishida E, Kinoshita C, Sone Y, Misaki A: Structures and antitumor activities of polysaccharides isolated from mycelium of Volvariella volvacea. Biosci Biotechnol Biochem 56;1308-1309, 1992
Saito H, Yoshioka Y, Uehara N, Aketagawa J, Tanaka S, Shibata Y: Relationship between conformation and biological response for (1\longrightarrow3)-beta-D-glucans in the activation of coagulation factor G from limulus am ebocyte lysate and host-mediated antitumor activity. Demonstration of single-helix conformation as a stimulant. Carbohydr Res 217;181-190, 1991
Gomaa K, Kraus J, Franz G, Roper H: Structural investigations of glucans from cultures of Glomerella cingulata Spaulding & von Schrenck. Carbohydr Res 217;153-161, 1991
Demleitner S, Kraus J, Franz G: Synthesis and antitumour activity of derivatives of curdlan and lichenan branched at C-6. Carbohydr Res 226;239-246, 1992
Tateishi T, Ohno N, Adachi Y, Yadomae, T: Increases in hematopoietic responses caused by beta-glucans in mice. Biosci Biotech Biochem 61;1548-1553, 1997
Tsuzuki A, Tateishi T, Ohno N, Adachi Y, Yadomae T: Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1\longrightarrow3)-beta-D-glucan preparation, Sonifilan, in cyclophospham ide-induced leukopenic mice. Biosci Biotech Biochem 63;104-110, 1999
Ohno N, Hashimoto T, Adachi Y, Yadomae T: Conformation dependency of nitric oxide synthesis of murine peritoneal macrophages by beta-glucans in vitro. Immunology Letters 52;1-7, 1996
Harada T: Studies on bacterial gel forming $\beta$ -1,3-glucans (Curdlan type polysaccharides) in Japan Proc IV IFS Ferment. Technol Today 603-607, 1972
Ohna N, Kurachi K, Yadomae T: Physicochemical properties and antitumor activities of carboxymethylated derivatives of glucan from Sclerotinia sclerotiorum. Chem Pharm Bull 36;1016-1025, 1988
Sasaki T, Abiko N, Nitta K, Takasuka N, Sugino Y: Antitumor activity of carboxymethylglucans obtained by carboxymethylation of (1{\longrightarrow}3)- $\beta$ -D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140. Eur J Cancer 15;211-215, 1979
Williams DL, McNamee RB, Jones EL, Pretus HA, Ensley HE, Browder IW, Di Luzio NR: A method for the solubilization of $\alpha$ (1{\longrightarrow}3)- $\beta$ -D-glucan isolated from Saccharomyces cerevisiae. Carbohydr Res 219;203-213, 1991
Han YW: Microbial levan. Adv Appl Microbiol 35;171-194, 1990
Kojima IT, Saito M, Iizuka N, Minamiura, Ono S: Characterization of levan produced by Serratia sp. J Ferment Bioeng 75;9-12, 1993
Chihara G : Recent progress in immunopharmacology and therapeutic effects of polysaccharides. Dev Biol Stand 77;19-197, 1992
Okamoto H, Shoin S, Koshimura S, Shimizu R: Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol 11;323-336, 1967
Oshimi K, Kano S, Takaku F, Okumura K: Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. J Natl Cancer Inst 65;1265-1269, 1980
Saito M, Ebina T, Koi M, Yamaguchi T, Kamade Y, Ishida N:Induction of interferon- $\gamma$ in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes. Cell Immunol 68;187-192, 1982
Ichimura O, Suzuki S, Saito M, Sugawara Y, Ishida N:Augmentation of interleukin 1 and interleukin 2 production by OK-432. Int J Immunopharmacol 7;263-270, 1985
Fukui H, Koshihara Y, Nagamuta M, Mizutani Y, Uchida A:Production of interleukin 6 by human spleen cells stimulated with streptococcal preparation OK-432. Immunol Lett 21;127-130, 1989
Misaki T, Watanabe Y, Iida Y, Hidaka A, Kasagi K, Fukushima H, Konishi J: Recruitment of T lymphocytes and induction of tumor necrosis factor in thyroid cancer by a local immunotherapy. Cancer Immunol Immunother 35;92-96, 1992
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.